首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Retrospective study of photodynamic therapy vs photodynamic therapy combined with chemotherapy and chemotherapy alone on advanced esophageal cancer
【24h】

Retrospective study of photodynamic therapy vs photodynamic therapy combined with chemotherapy and chemotherapy alone on advanced esophageal cancer

机译:光动力疗法与光动力疗法联合化疗和单纯化疗对晚期食管癌的回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To compare the short-term curative effect of photodynamic therapy (PDT), PDT combined with chemotherapy and chemotherapy alone on the advanced esophageal cancer patients.rnMethods: Retrospective analysis of 90 patients of esophageal cancer underwent PDT, PDT combined with chemotherapy and chemotherapy alone from 2004 to 2007 (stages III-IV), including 27 cases received PDT alone, 33 cases received PDT combined with chemotherapy and 30 cases chemotherapy alone. The enrolled patients were treated with intravenous administration of Photofrin as the photosensitizer at a dose of 2mg/kg. 630 nm laser irradiation was performed through optical fiber that passed through the biopsy channel of a flexible endoscope after 48 h. Two days later, the necrotic tissue was removed, and the primary sites and other newly identified lesions were subjected to a second irradiation and then the residual necrotic tissue was removed according to the patients' condition. Electronic endoscopy was performed to observe the effectiveness on tumor after 1 month. In PDT combined with chemotherapy group, chemotherapy regimen was 5-FU and DDP, administered 4 cycles after PDT and chemotherapy alone group only chemotherapy regimen 5-FU and DDP for four cycles. All the 90 patients were followed up for 2 years.rnResults: Symptomatic palliation rate of the PDT alone group, the complex treatment group and chemotherapy alone group was 85.2%, 93.9% and 60.0%, respectively, and effective rate under endoscopy was 85.2%, 90.9% and 63.3%, respectively, there is no statistically significant difference; the survival rate of 2 years was 29.6%, 54.5% and 16.7%, respectively, and mediumrnsurvival time is longer (III stages 13m, 22m, 10m; IV stages 7m, 5m, 4m), there is statistically significant difference (p = 0.046).rnConclusion: PUT combined with chemotherapy for the advanced esophageal cancer is superior to PDT alone and chemotherapy alone.
机译:目的:比较光动力疗法(PDT),光动力疗法(PDT)联合化学疗法和单纯化疗对晚期食管癌患者的近期疗效。方法:回顾性分析90例食管癌患者接受光动力疗法,光动力疗法联合化疗从2004年至2007年(III-IV阶段),仅PDT患者27例,PDT联合化疗33例,单独化疗30例。对入组患者进行静脉注射Photofrin作为光敏剂治疗,剂量为2mg / kg。在48小时后,通过穿过柔性内窥镜活检通道的光纤进行630 nm激光照射。两天后,切除坏死组织,对原发部位和其他新近发现的病变进行第二次照射,然后根据患者的病情去除残留的坏死组织。 1个月后进行电子内窥镜检查以观察对肿瘤的有效性。在PDT联合化疗组中,化疗方案为5-FU和DDP,仅在PDT和化疗后4个周期给药,仅化疗方案5-FU和DDP为四个周期。 90例患者均获随访2年。结果:PDT组,复合治疗组和单纯化疗组的症状缓解率分别为85.2%,93.9%和60.0%,内镜下有效率为85.2%。分别为90.9%和63.3%,差异无统计学意义; 2年生存率分别为29.6%,54.5%和16.7%,中生存期更长(III期13m,22m,10m; IV期7m,5m,4m),有统计学意义(p = 0.046)结论:PUT联合化疗治疗晚期食管癌优于单纯PDT和单纯化疗。

著录项

  • 来源
    《Photodiagnosis and Photodynamic Therapy》 |2010年第3期|p.139-143|共5页
  • 作者单位

    Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;

    rnDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;

    rnDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;

    rnDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;

    rnDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;

    rnDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;

    rnDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    photodynamic therapy (PDT); advanced esophageal cancer; chemotherapy; photofrin;

    机译:光动力疗法(PDT);晚期食道癌;化学疗法感光蛋白;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号